Research Topics
Species | Mark John MillanSummaryAffiliation: Institut de Recherches Servier Country: France Publications
| Collaborators
|
Detail Information
Publications
Specific labelling of serotonin 5-HT(1B) receptors in rat frontal cortex with the novel, phenylpiperazine derivative, [3H]GR125,743. A pharmacological characterizationM J Millan
Psychopharmacology Department, Centre de Recherches de Croissy, Institut de Recherches Servier, 125 Chemin de Ronde, 78290 Croissy Seine, Paris, France
Pharmacol Biochem Behav 71:589-98. 2002..In conclusion, [3H]GR125,743 is an appropriate tool for the radiolabelling of native, rat 5-HT(1B) receptors and permitted determination of the affinities of an extensive series of ligands at these sites...
S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent. II. A neurochemical, electrophysiological andMark J Millan
Institut de Recherches Servier, Centre de Recherches de Croissy, Psychopharmacology Department, 125, Chemin de Ronde, 78290 Croissy sur Seine, France
J Pharmacol Exp Ther 324:600-11. 2008..Furthermore, in line with its in vitro actions, it more potently blocks cerebral populations of D(3) versus D(2) receptors...
Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockadeMark J Millan
Department of Psychopharmacology, Centre de Recherches de Croissy, Institut de Recherches Servier, 125 Chemin de Ronde, Croissy Seine, 78290 Paris, France
Psychopharmacology (Berl) 177:448-58. 2005..The novel antidepressant agent, agomelatine, behaves as an agonist at melatonin receptors and as an antagonist at serotonin (5-HT)(2C) receptors...
The role of monoamines in the actions of established and "novel" antidepressant agents: a critical reviewMark J Millan
Psychopharmacology Department, IDR Servier, 125 Chemin de Ronde, Croissy Seine, Paris 78290, France
Eur J Pharmacol 500:371-84. 2004....
Activation of dopamine D1 receptors enhances cholinergic transmission and social cognition: a parallel dialysis and behavioural study in ratsBenjamin Di Cara
Institut de Recherches Servier, Department of Psychopharmacology, 125 Chemin de Ronde, 78290 Croissy sur Seine, France
Int J Neuropsychopharmacol 10:383-99. 2007..Although the relationship between these actions awaits further clarification, these data underpin the relevance of D1 receptors to CNS disorders in which cholinergic transmission and social cognition are disrupted...
An epigenetic framework for neurodevelopmental disorders: from pathogenesis to potential therapyMark J Millan
Unit for Research and Discovery in Neuroscience, IDR Servier, 125 Chemin de Ronde, 78290 Croissy sur Seine, Paris, France
Neuropharmacology 68:2-82. 2013..This article is part of the Special Issue entitled 'Neurodevelopmental Disorders'...
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapyMark J Millan
Institut de Recherche Servier, 78290 Croissy Seine, France
Nat Rev Drug Discov 11:141-68. 2012..This article critically discusses these issues, highlighting the challenges and opportunities for improving cognition in individuals suffering from psychiatric disorders...
S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: II. A behavioral, neurochemical, and electrophysiological characterizationAnne Dekeyne
Institut de Recherches Servier, Centre de Recherches de Croissy, Psychopharmacology Department, 125 Chemin de Ronde, 78290 Croissy Seine, France
J Pharmacol Exp Ther 340:765-80. 2012..In conclusion, S32212 displays a functional profile consistent with improved mood and cognitive performance, together with satisfactory tolerance...
S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterizationMark J Millan
Institut de Recherches Servier, Centre de Recherches de Croissy, Psychopharmacology Department, 125 Chemin de Ronde, 78290 Croissy Seine, France
J Pharmacol Exp Ther 340:750-64. 2012..Its promising profile in preclinical models potentially relevant to the treatment of depression is described in J Pharmacol Exp Ther 340:765-780, 2012...
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic applicationMark J Millan
Institut de Recherches Servier, Centre de Recherches de Croissy, Psychopharmacology Department, 125, Chemin de Ronde, 78290 Croissy Seine, France
Pharmacol Ther 110:135-370. 2006..Finally, a diversity of multi-target strategies is proposed for the more efficacious and rapid control of core and co-morbid symptoms of depression, together with improved tolerance relative to currently available agents...
Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategiesMark John Millan
Institut de Recherches Servier, Croissy sur Seine, France
Therapie 60:441-60. 2005....
N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectivesMark J Millan
Psychopharmacology Department, Institut de Recherches Servier, Centre de Recherches de Croissy, 78290 Croissy Seine, Paris, France
Psychopharmacology (Berl) 179:30-53. 2005..Activation of "co-agonist" N-methyl-D-aspartate (NMDA) and Glycine(B) sites is mandatory for the operation of NMDA receptors, which play an important role in the control of mood, cognition and motor function...
Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats: a characterization with alpha/beta-adrenoceptor subtype selective ligands, antidepressants, and antagonists at neuropeptide receptorsMark J Millan
Institut de Recherches Servier, Centre de Recherches de Croissy, Psychopharmacology Department, Croissy sur Seine, Paris, France
Int J Neuropsychopharmacol 10:579-93. 2007..The neurokinin-1 antagonist, GR205,171, mimics the interoceptive properties of reboxetine, possibly reflecting its elevation of extracellular levels of NE in corticolimbic structures...
The serotonin1A receptor partial agonist S15535 [4-(benzodioxan-5-yl)1-(indan-2-yl)piperazine] enhances cholinergic transmission and cognitive function in rodents: a combined neurochemical and behavioral analysisMark J Millan
Department of Psychopharmacology, Institut de Recherches Servier, Centre de Recherches de Croissy, 125 chemin de Ronde 78290 Croissy Seine, France
J Pharmacol Exp Ther 311:190-203. 2004..Its actions involve both blockade of postsynaptic 5-HT(1A) receptors and engagement of 5-HT(1A) autoreceptors...
The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in ratsMark J Millan
Psychopharmacology Department, Institut de Recherches Servier, Centre de Recherches de Croissy, 125 Chemin de Ronde, 78290 Croissy Seine, Paris, France
Psychopharmacology (Berl) 174:341-57. 2004..The role of dopamine D(3)/D(2) receptors in the control of locomotion is poorly understood...
S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: III. Actions in models of potential antidepressive and anxiolytic activity in comparison with ropiniroleMark J Millan
Institut de Recherches Servier, Centre de Recherches de Croissy, Psychopharmacology Department, Paris, France
J Pharmacol Exp Ther 309:936-50. 2004..Its actions are more pronounced than those of ropinirole and principally involve engagement of D(2) receptors...
S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: II. Actions in rodent, primate, and cellular models of antiparkinsonian activity in comparison to ropiniroleMark J Millan
Institut de Recherches Servier, Centre de Recherches de Croissy, Psychopharmacology Department, Paris, France
J Pharmacol Exp Ther 309:921-35. 2004..Although activation of D(2) receptors is crucial to the motor actions of S32504, engagement of D(3) receptors contributes to its neuroprotective properties...
Discriminative stimulus properties of S32504, a novel D3/D2 receptor agonist and antiparkinson agent, in rats: attenuation by the antipsychotics, aripiprazole, bifeprunox, N-desmethylclozapine, and by selective antagonists at dopamine D2 but not D3 receptMark J Millan
Department of Neuropharmacology, Institut de Recherches Servier, Centre de Recherches de Croissy, 125 Chemin de Ronde, 78290, Croissy sur Seine, Paris, France
Psychopharmacology (Berl) 191:767-82. 2007..J Pharmacol Exp Ther 309:936-950, 2004a; Millan et al., J Pharmacol Exp Ther 309:903-920, 2004b; Millan et al., J Pharmacol Exp Ther 309:921-935, 2004c)...
Selective blockade of dopamine D(3) versus D(2) receptors enhances frontocortical cholinergic transmission and social memory in rats: a parallel neurochemical and behavioural analysisMark J Millan
Department of Psychopharmacology, Institut de Recherches Servier, Croissy Seine, France
J Neurochem 100:1047-61. 2007..These data support the pertinence of D(3) receptors as a target for treatment of disorders in which cognitive function is compromised...
MicroRNA in the regulation and expression of serotonergic transmission in the brain and other tissuesMark J Millan
IDR Servier, 125 Chemin de Ronde, 78290 Croissy Seine, Paris, France
Curr Opin Pharmacol 11:11-22. 2011..The present article discusses the functionally and clinically important interplay amongst miRNAs and serotoninergic mechanisms in the brain, peripheral organs and cancerous tissue...
The melatonergic agonist and clinically active antidepressant, agomelatine, is a neutral antagonist at 5-HT(2C) receptorsMark J Millan
Department of Psychopharmacology, Institut de Recherches Servier, Croissy sur Seine, France
Int J Neuropsychopharmacol 14:768-83. 2011..It will be of interest to determine whether the neutral antagonist properties of agomelatine are related to its favourable clinical profile of antidepressant properties with few side-effects and no discontinuation syndrome...
The dopamine D3 receptor antagonist, S33138, counters cognitive impairment in a range of rodent and primate proceduresMark J Millan
Institut de Recherches Servier, Croissy sur Seine, France
Int J Neuropsychopharmacol 13:1035-51. 2010..These data underpin interest in D(3) receptor blockade as a strategy for improving cognitive performance in CNS disorders like schizophrenia and Parkinson's disease...
From the cell to the clinic: a comparative review of the partial D₂/D₃receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's diseaseMark J Millan
Dept of Psychopharmacology, Institut de Recherches Servier, 125 Chemin de Ronde, 78290 Croissy Seine Paris, France
Pharmacol Ther 128:229-73. 2010..The article concludes by highlighting perspectives for clarifying the mechanisms of action of piribedil and other antiparkinson agents, and for optimizing their clinical exploitation...
Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugsMark J Millan
Psychopharmacology Department, Institut du Recherches Servier, Centre de Recherches de Croissy, Paris, France
Neurotherapeutics 6:53-77. 2009..This review discusses the discovery and development of dual- and triple-acting antidepressants, focusing on novel concepts and new drugs disclosed over the last 2 to 3 years...
Cognitive impairment in schizophrenia: a review of developmental and genetic models, and pro-cognitive profile of the optimised D(3) > D(2) antagonist, S33138Mark J Millan
Institut de Recherches Servier, Croissy sur Seine, France
Therapie 63:187-229. 2008..It also reviews developmental and genetic risk factors for schizophrenia and their experimental modeling in rodents, with a particular emphasis on sensorimotor gating and cognitive deficits...
Signaling at G-protein-coupled serotonin receptors: recent advances and future research directionsMark J Millan
Institut de Recherche Servier, 125 Chemin de Ronde, 78290 Croissy sur Seine, Paris, France
Trends Pharmacol Sci 29:454-64. 2008..In view of the diversity of transduction mechanisms engaged by 5-HT, much of this discussion is relevant to other classes of G-protein-coupled receptors...
The melanin-concentrating hormone1 receptor antagonists, SNAP-7941 and GW3430, enhance social recognition and dialysate levels of acetylcholine in the frontal cortex of ratsMark J Millan
Division of Psychopharmacology, Institut de Recherches Servier, Croissy sur Seine, France
Int J Neuropsychopharmacol 11:1105-22. 2008..This profile differentiates MCH1 receptor antagonists from conventional anxiolytic and antidepressant agents...
S33138 (N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1] benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenyl-acetamide), a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: III. Actions in models of therapeutic activiMark J Millan
Institut de Recherches Servier, Centre de Recherches de Croissy, Psychopharmacology Department, 125 Chemin de Ronde, 78290 Croissy sur Seine, France
J Pharmacol Exp Ther 324:1212-26. 2008..In comparison with clinically available agents, S33138 displays, thus, a distinctive and promising profile of potential antipsychotic properties...
S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: I. Receptor-binding profile and functional acMark J Millan
Institut de Recherches Servier, Centre de Recherches de Croissy, Psychopharmacology Department, 125 Chemin de Ronde, 78290 Croissy sur Seine, France
J Pharmacol Exp Ther 324:587-99. 2008..In conclusion, S33138 possesses a distinctive receptor-binding profile and behaves, in contrast to clinically available antipsychotics, as a preferential antagonist at hD(3) versus hD(2) receptors...
S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: I. Cellular, electrophysiological, and neurochemical profile in comparison with ropiniroleMark J Millan
Psychopharmacology Department, Institut de Recherches Servier, Paris, France
J Pharmacol Exp Ther 309:903-20. 2004..Although the D(3)/D(2) agonist and antiparkinsonian agent ropinirole mimicked the profile of S32504, it was less potent. In conclusion, S32504 is a potent and selective agonist at dopamine D(3) and D(2) receptors...
The neurobiology and control of anxious statesMark J Millan
Psychopharmacology Department, Centre de Rescherches de Croissy, Institut de Recherches IDR Servier, 125 Chemin de Ronde, 78290 Croissy sur Seine, Paris, France
Prog Neurobiol 70:83-244. 2003....
Antiparkinsonian agent piribedil displays antagonist properties at native, rat, and cloned, human alpha(2)-adrenoceptors: cellular and functional characterizationM J Millan
Department of Psychopharmacology, Institut de Recherches Servier, Centre de Recherches de Croissy, Paris, France
J Pharmacol Exp Ther 297:876-87. 2001..6). In conclusion, piribedil displays essentially antagonist properties at cloned, human and cerebral, rat alpha(2)-ARs. Blockade of alpha(2)-ARs may, thus, contribute to its clinical antiparkinsonian profile...
S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramineM J Millan
Psychopharmacology Department, Institut de Recherches Servier, Centre de Recherches de Croissy, Paris, France
J Pharmacol Exp Ther 298:565-80. 2001..It enhances extracellular levels of 5-HT and NE throughout corticolimbic structures and selectively elevates dialysis levels of DA in frontal cortex versus subcortical regions...
S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramineM J Millan
Psychopharmacology Department, Institut de Recherches Servier, Centre de Recherches de Croissy, Paris, France
J Pharmacol Exp Ther 298:581-91. 2001..It exerts its actions more potently than venlafaxine and clomipramine, and its overall profile is distinct from those of citalopram and reboxetine...
Selective blockade of neurokinin (NK)(1) receptors facilitates the activity of adrenergic pathways projecting to frontal cortex and dorsal hippocampus in ratsM J Millan
Institut de Recherches Servier, Psychopharmacology Department, Croissy sur Seine, Paris, France
J Neurochem 76:1949-54. 2001..Adrenergic mechanisms may, thus, be involved in the potential antidepressant and other functional properties of NK(1) receptor antagonists...
Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypesMark J Millan
Department of Psychopharmacology, Institut de Recherches Servier, Centre de Recherches de Croissy, 125 Chemin de Ronde, 78290 Croissy Seine, Paris, France
J Pharmacol Exp Ther 303:791-804. 2002..In conclusion, an innovative multivariate analysis revealed marked heterogeneity in binding profiles of antiparkinson agents. Actions at sites other than hD(2) receptors likely participate in their (contrasting) functional profiles...
Improving the treatment of schizophrenia: focus on serotonin (5-HT)(1A) receptorsM J Millan
Psychopharmacology Department, Institut de Recherches Servier, Centre de Recherches de Croissy, Croissy Seine, Paris, France
J Pharmacol Exp Ther 295:853-61. 2000....
Anxiolytic properties of the selective, non-peptidergic CRF(1) antagonists, CP154,526 and DMP695: a comparison to other classes of anxiolytic agentM J Millan
Psychopharmacology Department, Institut de Recherches Servier, Centre de Recherches de Croissy, Paris, France
Neuropsychopharmacology 25:585-600. 2001..In conclusion, CP154,526 and DMP695 possess a common and distinctive profile of anxiolytic action expressed in the absence of an intrinsic influence upon monoamine release...
The Vogel conflict test: procedural aspects, gamma-aminobutyric acid, glutamate and monoaminesMark J Millan
Psychopharmacology Department, Institut de Recherches Servier, Centre de Recherches de Croissy, 125 Chemin de Ronde, 78290 Croissy Seine, Paris, France
Eur J Pharmacol 463:67-96. 2003..Indeed, in view of its clinical relevance, broader exploitation of the Vogel conflict test in the identification of novel classes of anxiolytic agents, and in the determination of their mechanisms of action, would prove instructive...
Descending control of painMark J Millan
Department of Psychopharmacology, Institut de Recherches Servier, 125 Chemin de Ronde, 78290 Croissy Seine, Paris, France
Prog Neurobiol 66:355-474. 2002..Knowledge of descending pathways has increased exponentially in recent years, so this is an opportune moment to survey their operation and therapeutic relevance to the improved management of pain...
S41744, a dual neurokinin (NK)1 receptor antagonist and serotonin (5-HT) reuptake inhibitor with potential antidepressant properties: a comparison to aprepitant (MK869) and paroxetineMark J Millan
Psychopharmacology Department, Institut de Recherches Servier, Centre de Recherches de Croissy, 125 Chemin de Ronde, 78290 Croissy sur Seine, France
Eur Neuropsychopharmacol 20:599-621. 2010..In conclusion, S41744 is an innovative NK(1) antagonist/5-HT reuptake inhibitor justifying further evaluation for treatment of stress-related disorders...
Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypesMark J Millan
Psychopharmacology Department, Institut de Recherches Servier, Centre de Recherches de Croissy, 125 Chemin de Ronde, 78290 Croissy Seine, France
Psychopharmacology (Berl) 168:397-409. 2003..Recently, we demonstrated that SSRIs, such as citalopram, enhance LA in mice exposed to a novel environment...
The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathwaysM J Millan
Department of Psychopharmacology, Institut de Recherches Servier, Croissy Seine, France
J Pharmacol Exp Ther 306:954-64. 2003..In conclusion, in contrast to melatonin, agomelatine behaves as an antagonist at 5-HT2B and 5-HT2C receptors: blockade of the latter reinforces frontocortical adrenergic and dopaminergic transmission...
N-methyl-D-aspartate receptor-coupled glycineB receptors in the pathogenesis and treatment of schizophrenia: a critical reviewM J Millan
Institut de Recherches Servier, 125 Chemin de Ronde, 78290 Croissy Seine, Paris, France
Curr Drug Targets CNS Neurol Disord 1:191-213. 2002..This article reviews the complex role of GLY(B) sites/NMDA receptors and their endogenous ligands in the pathogenesis and treatment of psychotic states...
Stereospecific blockade of marble-burying behaviour in mice by selective, non-peptidergic neurokinin1 (NK1) receptor antagonistsM J Millan
Psychopharmacology Department, Institut de Recherches Servier, Centre de Recherches de Croissy, 125 Chemin de Ronde, 78290 Croissy Sein, Paris, France
Neuropharmacology 42:677-84. 2002..Although the biological bases of this behaviour remain unclear, these observations underpin the contention that NK(1) receptors may be implicated in affective disorders...
Neurokinin1 antagonists potentiate antidepressant properties of serotonin reuptake inhibitors, yet blunt their anxiogenic actions: a neurochemical, electrophysiological, and behavioral characterizationAlain Gobert
Psychopharmacology Department, Institut de Recherches Servier, Centre de Recherches de Croissy, Paris, France
Neuropsychopharmacology 34:1039-56. 2009..Combined NK(1) receptor antagonism/5-HT reuptake inhibition may offer advantages in the management of depressed and anxious states...
The selective neurokinin (NK)(1) antagonist, GR205,171, stereospecifically enhances mesocortical dopaminergic transmission in the rat: a combined dialysis and electrophysiological studyFrançoise Lejeune
Institut de Recherches Servier, Centre de Recherches de Croissy, Psychopharmacology Department, 125 Chemin de Ronde, 78290 Croissy sur Seine, Paris, France
Brain Res 935:134-9. 2002..Activation of mesocortical dopaminergic pathways may be involved in the influence of NK(1) antagonists upon mood...
Cellular and behavioural profile of the novel, selective neurokinin1 receptor antagonist, vestipitant: a comparison to other agentsMauricette Brocco
Psychopharmacology Department, Institut de Recherches Servier, Centre de Recherches de Croissy, 125 Chemin de Ronde, Croissy Seine, Paris, France
Eur Neuropsychopharmacol 18:729-50. 2008..In conclusion, vestipitant is a potent NK(1) receptor antagonist: its actions support the utility of NK(1) receptor blockade in the alleviation of anxiety and, possibly, depression...
Pro-cognitive effects of 5-HT6 receptor antagonists in the social recognition procedure in rats: implication of the frontal cortexFlorence Loiseau
Department of Psychopharmacology, Institut de Recherches Servier, 125 Chemin de Ronde, 78290, Croissy sur Seine, Paris, France
Psychopharmacology (Berl) 196:93-104. 2008..5-HT6 receptor antagonists improve cognitive processes in rodents. However, their site(s) of action remains unexplored and their influence upon social memory has been little investigated...
Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. III. Agonist and antagonist properties at serotonin, 5-HT(1) and 5-HT(2), receptor subtypesAdrian Newman-Tancredi
Department of Psychopharmacology, Institut de Recherches Servier, Centre de Recherches de Croissy, 125 Chemin de Ronde, 78290 Croissy/Seine, Paris, France
J Pharmacol Exp Ther 303:815-22. 2002..Although all show modest (agonist) activity at 5-HT(1A) sites, their contrasting actions at 5-HT(2A) and 5-HT(2C) sites may be of particular significance to their functional profiles in vivo...
Differential modulation of efficiency in a food-rewarded "differential reinforcement of low-rate" 72-s schedule in rats by norepinephrine and serotonin reuptake inhibitorsAnne Dekeyne
Institut de Recherches Servier, Centre de Recherches de Croissy, Psychopharmacology Department, 125 Chemin de Ronde, 78290 Croissy-sur-Seine, France
Psychopharmacology (Berl) 162:156-67. 2002..Further, they support the interest of DRL 72-s procedures for the characterisation of diverse classes of antidepressant agent...
h5-HT(1B) receptor-mediated constitutive Galphai3-protein activation in stably transfected Chinese hamster ovary cells: an antibody capture assay reveals protean efficacy of 5-HTAdrian Newman-Tancredi
Department of Psychopharmacology, Institut de Recherches Servier, 125, Chemin de Ronde, Croissy-sur-Seine, Paris 78290, France
Br J Pharmacol 138:1077-84. 2003....
Antibody capture assay reveals bell-shaped concentration-response isotherms for h5-HT(1A) receptor-mediated Galpha(i3) activation: conformational selection by high-efficacy agonists, and relationship to trafficking of receptor signalingAdrian Newman-Tancredi
Department of Psychopharmacology, Institut de Recherches Servier, Croissy sur Seine, France
Mol Pharmacol 62:590-601. 2002..In contrast, partial agonists favor h5-HT(1A) receptor signaling to Galpha(i3) over a wide concentration range, whereas inverse agonists inhibit constitutive Galpha(i3) activation...
Stimulation by antipsychotic agents of mitogen-activated protein kinase (MAPK) coupled to cloned, human (h)serotonin (5-HT)(1A) receptorsDidier Cussac
Institut de Recherches Servier, Centre de Recherches de Croissy, Psychopharmacology Department, 125 Chemin de Ronde, 78290 Croissy-sur-Seine, France
Psychopharmacology (Berl) 162:168-77. 2002..g. S16924 and ziprasidone), via intermediate (e.g. clozapine) to low (e.g. haloperidol). Differential modulation of 5-HT(1A) receptor-coupled MAPK may contribute to their contrasting functional profiles...
Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agentsMauricette Brocco
Psychopharmacology Department, Institut de Recherches Servier, Centre de Recherches de Croissy, 125 Chemin de Ronde, 78290 Croissy/Seine, Paris, France
Pharmacol Biochem Behav 71:667-80. 2002..Although an influence upon arousal and/or anxiety is likely related to the increase in LA, the functional significance of this response requires additional elucidation...
Characterisation of Gs activation by dopamine D1 receptors using an antibody capture assay: antagonist properties of clozapineDidier Cussac
Psychopharmacology Department, Institut de Recherches Servier, Centre de Recherches de Croissy, 125, Chemin de Ronde, 78290 Croissy-sur-Seine, France
Eur J Pharmacol 485:111-7. 2004..Employing this novel technique, the typical and atypical antipsychotics, clozapine and haloperidol, respectively, both exhibited antagonist properties at dopamine D1 receptors...
Inhibitory and facilitory actions of isocyanine derivatives at human and rat organic cation transporters 1, 2 and 3: a comparison to human alpha 1- and alpha 2-adrenoceptor subtypesAnne Amphoux
INSERM U952, 75005, Paris, France
Eur J Pharmacol 634:1-9. 2010....
The selective serotonin(2A) receptor antagonist, MDL100,907, elicits a specific interoceptive cue in ratsAnne Dekeyne
Institut de Recherches Servier, Centre de Recherches de Croissy, Psychopharmacology Department, 125 Chemin de Ronde, 78290-Croissy-sur-Seine, France
Neuropsychopharmacology 26:552-6. 2002..In conclusion, selective blockade of 5-HT(2A) receptors by MDL100,907 elicits a discriminative stimulus in rats which appears to be specifically mediated via 5-HT(2A) as compared with 5-HT(2B) and 5-HT(2C) receptors...
The CRF1 receptor antagonist, DMP695, abolishes activation of locus coeruleus noradrenergic neurones by CRF in anesthetized ratsFrançoise Lejeune
Psychopharmacology Department, Institut de Recherches Servier, Centre de Recherches de Croissy, 125 Chemin de Ronde, 78290 Croissy Seine, Paris, France
Eur J Pharmacol 464:127-33. 2003..These data demonstrate antagonist properties of DMP695 at central CRF(1) receptors excitatory to ascending noradrenergic neurones, an action which may contribute to its distinctive profile of anxiolytic properties...
Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. II. Agonist and antagonist properties at subtypes of dopamine D(2)-like receptor and alpha(1)/alpha(2)-adrenoceptorAdrian Newman-Tancredi
Department of Psychopharmacology, Institut de Recherches Servier, Centre de Recherches de Croissy, 125 Chemin de Ronde, 78290 Croissy/Seine, Paris, France
J Pharmacol Exp Ther 303:805-14. 2002..In conclusion, antiparkinson agents display diverse agonist and antagonist properties at multiple subtypes of D(2)-like receptor and alpha(1)/alpha(2)-AR, actions, which likely contribute to their contrasting functional profiles...
Differential activation of Gq/11 and Gi(3) proteins at 5-hydroxytryptamine(2C) receptors revealed by antibody capture assays: influence of receptor reserve and relationship to agonist-directed traffickingDidier Cussac
Institut de Recherches Servier, Psychopharmacology Department, Chemin de Ronde, Croissy Seine, Paris, France
Mol Pharmacol 62:578-89. 2002..In conclusion, h5-HT(2C) receptors couple to both Gq/11 and Gi(3) in CHO cells, and efficacy for G protein subtype activation is both ligand- and receptor reserve-dependent...
Discriminative stimulus properties of the selective and highly potent alpha2-adrenoceptor agonist, S18616, in rats: mediation by the alpha2A subtype, and blockade by the atypical antidepressants, mirtazapine and mianserinAnne Dekeyne
Institut de Recherches Servier, Centre de Recherches de Croissy, Psychopharmacology Department, 125, Chemin de Ronde, 78290 Croissy sur Seine, Paris, France
Neuropharmacology 51:718-26. 2006..In conclusion, S18616 elicits a robust DS in rats that principally reflects engagement of alpha2A-ARs. This novel procedure should prove useful in the characterisation of psychoactive drugs which interact with alpha2-ARs...
Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptorsMauricette Brocco
Psychopharmacology Department, Servier Research Institute, Croissy Research Center, Paris, France
Behav Pharmacol 17:559-72. 2006..In conclusion, principally via recruitment of D2 receptors, piribedil exerts robust and specific antidepressant-like actions in diverse rodent models...
Ligand modulation of [35S]GTPgammaS binding at human alpha(2A), alpha(2B) and alpha(2C) adrenoceptorsValérie Audinot
Département de Pharmacologie Moléculaire et Cellulaire, Institut de Recherches Servier, 125, Chemin de Ronde, 78290 Croissy sur Seine, France
Cell Signal 14:829-37. 2002..Moreover, they emphasize the continuing need for alpha(2)-AR subtype-selective antagonists in order to define further the roles and therapeutic relevance of halpha(2A)-, halpha(2B)-, and halpha(2C)-AR...
Quantification and pharmacological characterization of dialysate levels of noradrenaline in the striatum of freely-moving rats: release from adrenergic terminals and modulation by alpha2-autoreceptorsAlain Gobert
Psychopharmacology Department, Institut de Recherches Servier, Centre de Recherches de Croissy, 125 Chemin de Ronde, Croissy Seine 78290, France
J Neurosci Methods 140:141-52. 2004..A role of dopaminergic terminals in the reuptake of NA likely explains the elevation in its levels elicited by DA reuptake-inhibitors and D3/D2 receptor antagonists...
Improvement in the selectivity and metabolic stability of the serotonin 5-HT(1A) ligand, S 15535: a series of cis- and trans-2-(arylcycloalkylamine) 1-indanolsJean Louis Peglion
Institut de Recherches Servier, 11 rue des Moulineaux, 92150 Suresnes et 125 Chemin de Ronde, 78290 Croissy sur Seine, France
J Med Chem 45:165-76. 2002....
Influence of positive allosteric modulators on GABA(B) receptor coupling in rat brain: a scintillation proximity assay characterisation of G protein subtypesClotilde Mannoury La Cour
Psychopharmacology Department, Institut de Recherche Servier, Croissy sur Seine, France
J Neurochem 105:308-23. 2008..PAMs more markedly enhanced efficacy of coupling to Go versus Gi(1/3). It will be of interest to confirm these observations employing complementary techniques and to evaluate their potential therapeutic significance...
Modulations of the amide function of the preferential dopamine D3 agonist (R,R)-S32504: improvements of affinity and selectivity for D3 versus D2 receptorsJean Louis Peglion
Institut de Recherches Servier, Chemistry B Departement, Suresnes, France
Bioorg Med Chem Lett 19:2133-8. 2009..Conversely, when the primary amide function was integrated in a lactam ring, an enhancement of affinity and selectivity was attained for the five-membered ring lactam but also for its five-membered ring lactone analogue...
Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositolsDidier Cussac
Department of Psychopharmacology, Institut de Recherches Servier, 125 Chemin de Ronde, 78290 Croissy Sur Seine Paris, France
Naunyn Schmiedebergs Arch Pharmacol 365:242-52. 2002..Although several antagonists clearly differentiated h5-HT2C from h5-HT2B receptors under these conditions, highly selective agonists remain to be identified...
Actions of novel agonists, antagonists and antipsychotic agents at recombinant rat 5-HT6 receptors: a comparative study of coupling to G alpha sDelphine S Dupuis
Department of Psychopharmacology, Institut de Recherches Servier, 125 Chemin de Ronde, 78290 Croissy sur Seine, France
Eur J Pharmacol 588:170-7. 2008..Though 5-HT6 receptor blockade is not indispensable for therapeutic efficacy, it may well play a role in the functional actions of certain antipsychotic agents...
Blockade of dopamine D(3) receptors in frontal cortex, but not in sub-cortical structures, enhances social recognition in rats: similar actions of D(1) receptor agonists, but not of D(2) antagonistsFlorence Loiseau
Institut de Recherches Servier, Department of Psychopharmacology, 125 Chemin de Ronde, 78290 Croissy sur Seine, Paris, France
Eur Neuropsychopharmacol 19:23-33. 2009..63), into the FCX though it was also active (0.63) in the nucleus accumbens. These data suggest that D(3) receptors modulating social recognition are localized in FCX, and underpin their pertinence as targets for antipsychotic agents...
S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent modelsAnne Dekeyne
Department of Psychopharmacology, Institut de Recherches Servier, Centre de Recherches de Croissy, 125 Chemin de Ronde, Croissy Seine, France
Psychopharmacology (Berl) 199:549-68. 2008..Serotonin (5-HT)(2C) receptors are implicated in the control of mood, and their blockade is of potential interest for the management of anxiodepressive states...
Discriminative stimulus properties of the atypical antidepressant, mirtazapine, in rats: a pharmacological characterizationAnne Dekeyne
Department of Neuropharmacology, Institut de Recherches Servier, Centre de Recherches de Croissy 125 Chemin de Ronde, 78290, Croissy sur Seine, Paris, France
Psychopharmacology (Berl) 203:329-41. 2009..Though interoceptive properties of antidepressants have been described, discriminative stimulus (DS) properties of mirtazapine, which does not affect monoamine reuptake, remain uncharacterized...
Signaling pathways leading to phosphorylation of Akt and GSK-3β by activation of cloned human and rat cerebral D₂and D₃ receptorsClotilde Mannoury La Cour
Institut de Recherches Servier, Psychopharmacology Department, 125 Chemin de Ronde, 78290 Croissy sur Seine, France
Mol Pharmacol 79:91-105. 2011..However, significant differences were seen regarding the involvement of PLC, calmodulin, and ERK1/2...
[Dopamine D3 receptors as a novel target for improving the treatment of schizophrenia]Mark J Millan
IDR Servier, , 125, Chemin de Ronde, 78290 Croissy-sur-Seine, France
Med Sci (Paris) 21:434-42. 2005..The first clinical studies for the evaluation of this hypothesis have recently got underway...
